Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel/Carboplatin plus Maintenance Letrozole vs Letrozole Monotherapy in Low-Grade Serous Ovarian or Peritoneal Carcinoma
KCT0005153Phase 3Recruiting
- Sponsor
- Korean Gynecologic Oncology Group
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel, carboplatin, letrozole in low-grade serous ovarian carcinoma (LGSOC), low-grade serous peritoneal adenocarcinoma, sponsored by Korean Gynecologic Oncology Group. Started Mar 2021; status: recruiting.
02
Drugs
paclitaxelcarboplatinletrozole
03
Conditions
low-grade serous ovarian carcinoma (LGSOC)low-grade serous peritoneal adenocarcinoma
Beyond the preview
Go deeper on KCT0005153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005153.